Chemotherapy-free treatment with inotuzumab ozogamicin and blinatumomab for older adults with newly diagnosed, Ph-negative, CD22-positive, B-cell acute lymphoblastic leukemia: Alliance A041703.
- Citation:
- J Clin Oncol vol 41 (suppl 16) 7006
- Meeting Instance:
- ASCO 2023
- Year:
- 2023
- Type:
- Abstract
- Sub type:
- Oral
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- epreprint
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- None
- Pharmas:
- Grants:
- U10CA180821, U10CA180882; U10CA180820 (EA)
- Corr. Author:
- Authors:
- Matthew J. Wieduwilt Jun Yin Oudom Kour Rebecca Teske Wendy Stock Kenneth Byrd Kimberley Doucette James Mangan Gregory Masters Alice Mims Katarzyna J. Jamieson Shira Dinner Ali Bseiso Geoffrey L. Uy Richard M. Stone
- Networks:
- CA249, CAPITAL, CHRISTIANA, KANSAS, LAPS-IL036, LAPS-IL057, LAPS-MA036, LAPS-MO011, LAPS-NC007, LAPS-OH007, NC002, WINCORP
- Study
- Alliance-A041703
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords: